Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.711
+0.151 (3.32%)
Jan 14, 2026, 1:06 PM EST - Market open
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $44.2 million as of January 14, 2026.
Market Cap
44.20M
Enterprise Value
6.55M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.71
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $44.20M, a decrease of -74.11%. That is a compound annual growth rate of -83.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 42.78M | 6.05% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.71B |
| Johnson & Johnson | 513.88B |
| AbbVie | 387.11B |
| UnitedHealth Group | 303.66B |
| AstraZeneca | 291.77B |
| Novartis AG | 274.30B |
| Merck & Co. | 268.53B |
| Novo Nordisk | 263.26B |